Genenta Science SPA (GNTA) Stock Analysis

$1.000

+0.009 (+0.94%)At close

Loading chart…

High: 1.080
Open: 1.020
VWAP: 1.03
Vol: 58.85K
Mkt Cap: 56.65M
Low: 1.000
Amount: 60.42K
EV/EBITDA, TTM: 0.00

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

www.genenta.com

AI analysis of Genenta Science SPA (GNTA)

hold

Given the current price of $1.00 and the RSI of 20.266 indicating oversold conditions, GNTA may present a potential buying opportunity in the long term. However, the significant 1-year change of -71.65% raises concerns about the company's stability and market performance.

Valuation Metrics

The current forward P/E ratio for Genenta Science SPA (GNTA) is 0.00, compared to its 5-year average forward P/E of -8.73.

Forward P/E

Overvalued

5Y Average P/E

-8.73

Current P/E

0.00

Overvalued

-3.06

Undervalued

-14.41

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-4.87

Current EV/EBITDA

0.00

Overvalued

0.38

Undervalued

-10.12

Forward P/S

Fair

5Y Average P/S

25.82

Current P/S

0.00

Overvalued

85.26

Undervalued

-33.61

Alphio AI Price Scenarios for GNTA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%GNTA

$4.84

Scenario price

Base

Base · 50%GNTA

$4.55

Scenario price

Bear

Bear · 25%GNTA

$4.19

Scenario price

Events Timeline

2026-07-23 (ET)